Shares of Novavax slid 6.92% to $206.18 at 15:21 EST on Tuesday, following last session’s downward trend. NASDAQ Composite is falling 1.16% to $13,754.02, following last session’s downward trend, This seems, so far, an all-around rough trend exchanging session today.
Novavax’s last close was $221.50, 60.87% under its 52-week high of $331.68.
Novavax’s sales growth is 8542.9% for the present quarter and 1971.3% for the next. The company’s growth estimates for the present quarter is a negative 356.9% and positive 930% for the next.
Year-on-year quarterly revenue growth grew by 3072.2%, now sitting on 475.6M for the twelve trailing months.
Novavax’s Stock Yearly Top and Bottom Value
Novavax’s stock is valued at $206.18 at 15:21 EST, way under its 52-week high of $331.68 and way above its 52-week low of $14.38.
Novavax’s Moving Average
Novavax’s worth is under its 50-day moving average of $210.81 and way above its 200-day moving average of $149.03.
More news about Novavax.